Centre for Endocrinology and Reproductive Medicine

The Centre for Endocrinology and Reproductive Medicine (CERM), also known as CERM-Hungaria, is a specialized medical and research institution based in Rome, Italy, dedicated to reproductive health and endocrinology. The center is a prominent sponsor of clinical trials investigating innovative treatments for recurrent implantation failure (RIF), recurrent pregnancy loss (RPL), and endometriosis. CERM's research portfolio includes the evaluation of cytokines like G-CSF and GM-CSF, GnRH antagonists such as Degarelix and Cetrorelix, and personalized hormonal therapies to improve outcomes in assisted reproductive technology (ART). Led by experts Dr. Marco Sbracia and Dr. Fabio Scarpellini, the center collaborates with international academic institutions to advance the understanding of maternal-fetal crosstalk and endometrial receptivity.